摘要
目的为基层医疗机构开展同质化肿瘤专科药学服务提供参考。方法在区域医联体内构建同质化的肿瘤药学门诊服务模式和工作流程,收集肿瘤药学门诊的实践数据,对该模式的运行效果进行初步分析和评价。结果在该模式实施后的1年多内,肿瘤药学门诊共服务患者123例(170例次);对59例患者开展潜在药物相互作用筛查83例次;对78例患者进行不良反应及合并症状干预,其中65.4%的患者经药师干预后不良反应分级及症状改善;电话或微信随访419例次,其中患者用药教育294例次,97.6%的患者能够充分理解并采纳用药宣教内容,87.1%的患者用药依从性良好;55例次(32.3%)药师干预及用药调整被患者接受;95.1%的就诊患者对肿瘤药学门诊服务表示非常满意。结论在医联体内构建同质化的肿瘤药学门诊服务模式,可为患者提供专业的合理用药指导和科学用药监管,同时也可助力医联体肿瘤药学服务质量实现同质化发展。
OBJECTIVE To provide reference for primary medical institutions to carry out homogeneous oncology pharmacy service.METHODS The model and procedure of homogeneous oncology pharmacy outpatient service were established in the medical alliances.The practice data of oncology pharmacy outpatient service were retrospectively analyzed,and preliminary analysis and evaluation were conducted for the effects of pharmacy service.RESULTS During more than one year of the practice of the model,a total of 123 patients(170 case times)were served in the oncology pharmacy department;83 case times of potential drug interaction were screened for 59 patients;78 patients were intervened with adverse reactions and combined symptoms by pharmacists,of which 65.4% of patients’adverse reaction grades and combined symptoms improved after intervention by pharmacists;419 case times were followed up by telephone or We Chat,including 294 case times were educated on medication;97.6% of patients understood and adopted medication education,87.1% of patients had good medication compliance;55 case times(32.3%)of pharmacist intervention and medication adjustment were accepted by patients;95.1% of the patients were very satisfied with oncology pharmacy outpatient service.CONCLUSIONS To construct a homogeneous tumor pharmacy outpatient service model in the medical alliances,can provide professional rational drug use guidance and scientific medication regulation for patients,and also can help the quality of medical alliance oncology pharmacy services to achieve homogeneous development.
作者
徐蕊
王祺茹
叶玲
韩毓
张宁
王萌萌
翟青
杜琼
XU Rui;WANG Qiru;YE Ling;HAN Yu;ZHANG Ning;WANG Mengmeng;ZHAI Qing;DUQiong(Dept.of Pharmacy,Shanghai Minhang District Cancer Hospital/Minhang Branch,Fudan University Cancer Hospital,Shanghai 200240,China;Dept.of Medical,Shanghai Minhang District Cancer Hospital/Minhang Branch,Fudan University Cancer Hospital,Shanghai 200240,China;Dept.of Medical Oncology,Shanghai Minhang District Cancer Hospital/Minhang Branch,Fudan University Cancer Hospital,Shanghai 200240,China;Dept.of Pharmacy,Fudan University Cancer Hospital,Shanghai 200032,China;Dept.of Oncology,Shanghai Medical College,Fudan University,Shanghai 200240,China)
出处
《中国药房》
CAS
北大核心
2022年第20期2540-2544,共5页
China Pharmacy
基金
上海市科学技术委员会科研计划项目(No.19DZ1910705)
上海市闵行区卫生健康系统优秀青年药学人才项目(No.mwyjyx03)
上海市闵行区自然科学研究课题(No.2020MHZ003)。
关键词
肿瘤药学门诊
医联体
药学服务
同质化
oncology pharmacy outpatient service
medical alliance
pharmaceutical care
homogenization
作者简介
第一作者:徐蕊,主管药师。研究方向:肿瘤药学。E-mail:ruixu19911992@163.com;通信作者:杜琼,主管药师。研究方向:肿瘤药学。E-mail:dujoan-88@163.com。
